Schering Doubles Legal Reserves To $500 Mil. For Boston Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Company adds $250 mil. in litigation reserves primarily relating to the Boston U.S. Attorney’s investigation into Schering’s marketing practices. Schering also took a $9 mil. charge for facility consolidation during the second quarter.
You may also be interested in...
Claritin Rebate Settlement Leaves Door Open For Boston Investigation
Schering-Plough's July 30 settlement with the Philadelphia U.S. Attorney does not preclude additional criminal prosecution of the company over its Medicaid "best price" reporting for Claritin
Schering Documents On Bundled Discounts Subpoenaed By Boston Prosecutor
The investigation focuses on bundling practices involving seven drugs. Schering also reports it has settled most claims in pricing conspiracy lawsuits filed by pharmacies.
Savient Delays 10-Q Filing Due To Oxandrin Return Reserve Errors
The firm will restate first quarter and 2004 year-end results due to less-than-expected returns of the anabolic agent.